Graffinity, m-phasys in GPCR deal

Graffinity (Heidelberg, Germany) and m-phasys (Tubingen, Germany) will develop and market a G protein-coupled receptor (GPCR) platform for drug discovery. The joint technology will combine Graffinity'...